You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Purpura, Thrombotic Thrombocytopenic

Showing 1 - 25 of 1,689
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

TTP - Thrombotic Thrombocytopenic Purpura Trial in Ankara

Recruiting
  • TTP - Thrombotic Thrombocytopenic Purpura
    • Ankara, Turkey
      Baskent Universtiy Faculty of Medicine
    Jul 15, 2023

    Caplacizumab in Treatment of Acquired Thrombotic

    Not yet recruiting
    • Acquired Thrombotic Thrombocytopenic Purpura
    • Cologne, Germany
      University Hospital of Cologne
    May 25, 2023

    Purpura, Thrombocytopenic Trial in Sevilla (Standard clinical practice)

    Not yet recruiting
    • Purpura, Thrombocytopenic
    • Standard clinical practice
    • Sevilla, Andalucia, Spain
      Hospital Universitario Virgen del Rocío
    Jun 13, 2023

    Thrombotic Thrombocytopenic Purpura (TTP) Trial (TAK-755)

    No longer available
    • Thrombotic Thrombocytopenic Purpura (TTP)
    • (no location specified)
    Mar 3, 2023

    TTP Patients: Italian Experience (ROSCAPLI)

    Recruiting
    • Thrombotic Thrombocytopenic Purpura
    • Roma, Italy
      FPG
    Mar 14, 2023

    Construction of a Database for TTP

    Recruiting
    • TTP - Thrombotic Thrombocytopenic Purpura
    • collection data
    • Suzhou, Jiangsu, China
      the first affiliated hospital of Soochow university
    Oct 5, 2022

    Thrombotic Thrombocytopenic Purpura (TTP) Trial (TAK-755)

    Not yet recruiting
    • Thrombotic Thrombocytopenic Purpura (TTP)
    • TAK-755
    • (no location specified)
    Feb 9, 2023

    Thrombotic Thrombocytopenic Purpura Trial (Aspirin tablet, Placebo)

    Not yet recruiting
    • Thrombotic Thrombocytopenic Purpura
    • Aspirin tablet
    • Placebo
    • (no location specified)
    Sep 30, 2022

    .German TTP-Registry (Thrombotic Thrombocytopenic Purpura)

    Recruiting
    • Thrombotic Thrombocytopenic Purpura
      • Mainz, Germany
        University Hospital Mainz, Hematology
      May 20, 2022

      Thrombotic Thrombocytopenic Purpura Trial (Caplacizumab, Corticosteroids, anti-CD20 antibody)

      Not yet recruiting
      • Thrombotic Thrombocytopenic Purpura
      • (no location specified)
      Aug 8, 2022

      Thrombotic Thrombocytopenic Purpura Trial in Japan (Caplacizumab (ALX-0081), Plasma exchange (PE), Corticosteroid treatment

      Completed
      • Thrombotic Thrombocytopenic Purpura
      • Caplacizumab (ALX-0081)
      • +3 more
      • Iruma-Gun, Japan
      • +11 more
      Jan 30, 2023

      Hereditary Thrombotic Thrombocytopenic Purpura

      Recruiting
      • Thrombotic Thrombocytopenic Purpura
      • +4 more
      • Observation
      • Oklahoma City, Oklahoma
      • +6 more
      Nov 1, 2022

      Improvement of Immunologic and Molecular Techniques for

      Not yet recruiting
      • Acquired Thrombotic Thrombocytopenic Purpura
      • ADAMTS13 Activity Assays
      • (no location specified)
      May 26, 2022

      Thrombotic Thrombocytopenic Purpura Trial in Paris (Sulfate, Magnesium, Placebo - Concentrate)

      Active, not recruiting
      • Thrombotic Thrombocytopenic Purpura
      • Sulfate, Magnesium
      • Placebo - Concentrate
      • Paris, France
        Saint Louis hospital
      Oct 28, 2021

      Efficiency of Caplacizumab in the Treatment of aTTP

      Recruiting
      • Acquired Thrombotic Thrombocytopenic Purpura
      • Cologne, Germany
        University Hospital of Cologne
      Dec 28, 2021

      TTP Patients: Italian Experience (ROSCAPLI)

      Not yet recruiting
      • Thrombotic Thrombocytopenic Purpura, Acquired
        • Rome, Italy
          Fondazione Policlinico Universitario Agostino Gemelli, IRCCS
        Feb 21, 2022

        Thrombotic Thrombocytopenic Purpura, Acquired Trial in Beijing (Bortezomib Injection)

        Not yet recruiting
        • Thrombotic Thrombocytopenic Purpura, Acquired
        • Bortezomib Injection
        • Beijing, (Select), China
          Peking Union Medical College Hospital
        Nov 22, 2021

        The ConNeCT Study: Neurological Complications of TTP

        Recruiting
        • Thrombotic Thrombocytopenic Purpura
        • Questionnaires (including PHQ-9, TYM and SF-36)
        • Liverpool, United Kingdom
          Royal Liverpool University Hospital
        Aug 2, 2021

        Thrombotic Thrombocytopenic Purpura Trial in United States (rituximab)

        Completed
        Has Results
        • Thrombotic Thrombocytopenic Purpura
        • rituximab
        • Atlanta, Georgia
        • +3 more
        Aug 13, 2021

        Caplacizumab-treated Pediatric Immune-mediated Thrombocytopenic

        Active, not recruiting
        • Immune-mediated Thrombocytopenic Purpura
        • Chilly-Mazarin, France
          Sanofi-Aventis
        Aug 8, 2022

        Congenital Thrombotic Thrombocytopenic Purpura Trial in Worldwide (TAK-755)

        Recruiting
        • Congenital Thrombotic Thrombocytopenic Purpura
        • TAK-755
        • Atlanta, Georgia
        • +20 more
        Mar 29, 2022

        Thrombotic Thrombocytopenic Purpura (TTP) Trial in Worldwide (BAX930, Standard of care)

        Recruiting
        • Thrombotic Thrombocytopenic Purpura (TTP)
        • BAX930
        • Standard of care
        • Atlanta, Georgia
        • +29 more
        May 4, 2022

        (PRO) Instrument for Congenital Thrombotic Thrombocytopenic

        Completed
        • Congenital Thrombotic Thrombocytopenic Purpura
        • No intervention
        • Atlanta, Georgia
        • +3 more
        Mar 15, 2021

        Thrombotic Thrombocytopenic Purpura, Acquired Trial (Caplacizumab)

        Not yet recruiting
        • Thrombotic Thrombocytopenic Purpura, Acquired
        • (no location specified)
        Jan 19, 2021

        Acquired Thrombotic Thrombocytopenic Purpura Trial in Worldwide (Caplacizumab, Standard of Care)

        Completed
        Has Results
        • Acquired Thrombotic Thrombocytopenic Purpura
        • Caplacizumab
        • Standard of Care
        • Saint Louis, Missouri
        • +44 more
        Mar 21, 2022